Abstract To evaluate the role of purines in antiviral treatments in plants, ribavirin (RB) and tiazofurin (TZ) were applied in combination with guanosine (GS) or adenosine (AS) in in vitro grapevine or tobacco explants infected by Grapevine leafroll associated virus 3 (GLRaV-3) and Cucumber mosaic virus (CMV), respectively. Using a microelectrochemical (trans-plasma membrane electron transport, t-PMET) technique, in vivo assay of free reduced nicotinamide adenine dinucleotide (NADH) was also carried out to estimate the inosine monophosphate dehydrogenase inhibition caused by drugs. Antiviral effectiveness of TZ, evaluated as virus-free explants or virus copies, was significantly hindered by GS in both species, while AS did not interfere with the drugs. GS, but not AS, slightly hindered the antiviral effectiveness of RB. With regard to NADH tests, t-PMET inhibition caused by RB and TZ was dose dependent and the interference of drugs with the NAD ? /NADH conversion was confirmed by NADH content. Findings indicate that exogenous GS up to 0.50 mM replenished the GS pool depleted by drugs, contrasting antiviral action. At higher doses of GS, the TZ antiviral action was completely inhibited and exogenous GS caused a feedback that reduced t-PMET activity. The reversal was partially against RB, suggesting that the reduction of the GS pool contributed to the antiviral activity of RB, but it was not the only cause of antiviral effectiveness.
Introduction
For the biosynthesis of guanine nucleotides needed for translation, transcription and replication processes (Allison and Eugui 2000) , inosine monophosphate dehydrogenase (IMPDH) is a key enzyme. In animals, it is believed that IMPDH inhibition affects not only the proliferation of eukaryotic cells but also replication of DNA and RNA (Markland et al. 2000) . Some IMPDH inhibitors are derived from the structure of ribavirin (RB), a synthetic nucleoside analog of guanosine (GS), and this class of molecules has marked antiviral activity. Indeed, many molecules have been tested in this regard, for example tiazofurin (TZ). IMPDH inhibitors are crucial for the transcription of triphosphate ribonucleotides, and as such are central to final inhibiting stages of nucleic acid Communicated by E. K.-Gebarowska. replication in viruses. In animal cells, the main target of these molecules in terms of antiviral activity is IMPDH and the action of its inhibitor reduces the intracellular pool of GS which also prevents the synthesis of viral RNA (Franchetti et al. 1996) .
Several investigators (Nascimento et al. 2003; Guta et al. 2010; Panattoni et al. 2013a Panattoni et al. , 2014 Skiada et al. 2013; Guazzelli et al. 2015) have found that some animal IMPDH inhibitors have antiviral activity in plants and, based on the data, the mechanism of antiviral action found in animals can occur in plants as well. This fact highlights the important role of IMPDH in viral replication. In animals, IMPDH is considered to be an NAD-dependent enzyme that controls the de novo synthesis of purine (Petrelli et al. 2013) . Studies have found a correlation between virus infection and higher NADH contents: via a microelectrochemical technique to measure trans-plasma membrane electron transports (t-PMET), this parameter can be assayed in plant tissues and in vivo cells (Taylor and Chow 2001; Luvisi et al. 2012) . t-PMET are targets for the development of antiviral drugs as they permit extracellular oxidants to be reduced at the expense of cellular reducing equivalents that may derive from NADH (Del Principe et al. 2011) . Panattoni et al. (2013b) found that t-PMET activity in plants was diminished by IMPDH inhibitors, which suggests that inhibitors interfere with the NAD ? / NADH conversion.
GS reversed the antiviral effectiveness of drugs such as RB in animal cells, suggesting that inhibition of IMPDH, and thus depletion of the intracellular guanosine triphosphate (GTP) pool (Takhampunya et al. 2006; Mitsuhashi et al. 2010) , may be one mode of antiviral action. In addition, GS reversed the apoptotic effect of IMPDH inhibitor gnidilatimonoein in K562 cells (Nouri et al. 2011) .
This paper reports the application of RB and TZ in combination with GS and AS in in vitro grapevine or tobacco explants infected by viruses [(Grapevine leafroll associated virus 3 (GLRaV-3) or Cucumber mosaic virus (CMV)] to evaluate the modulation of viral infection by exogenous purines. The effects of NAD ? /NADH conversion caused by IMPDH inhibition were also evaluated using an in vivo assay.
Materials and methods

Plant materials
In vitro grapevine explants were obtained following the Panattoni et al. (2007) protocol from field-grown V. vinifera cv. Sangiovese naturally infected singularly by GLRaV-3 and virus-free V. vinifera cv. Sangiovese plants, considering viruses included in the European Commission directive 2005/43/EC. Leafroll disease is an economically harmful graft-transmissible disease of grapevines and occurs in all grapevine-growing countries (Cabaleiro et al. 2008 ). An analogous procedure was carried out to obtain in vitro Nicotiana tabacum cv. Turkish explants artificially infected by CMV, while healthy plants were used as control. Nodes were collected and surface sterilized before transfer to aseptic culture tubes with fresh Murashige and Skoog (1962) or Quoirin and Lepoivre (1977) proliferating media for tobacco and grapevine, respectively. All explants were maintained in a controlled environment chamber that assured maintenance of sanitary conditions, with a temperature regime of 22 ± 1°C, 16 h photoperiod, 50 lEm -2 s -1 . Explants were transferred to fresh proliferating medium at 15-and 30-day intervals for tobacco and grapevine, respectively. After an acclimatization period, the sanitary condition of each plantlet was confirmed by RT-PCR. Total RNA was extracted from grapevine or tobacco samples according to the methods described by MacKenzie et al. (1997) and RNA was detected using a one-step RT-PCR procedure based on the One Step RT-PCR kit (Qiagen, Hilden, Germany). DNA primer pairs for amplification were those designed by Bertolini et al. (2003) for CMV and Turturo et al. (2005) for GLRaV-3.
Chemical treatments
To evaluate the effectiveness of chemicals on health status, RB, TZ, GS or AS were hydrated in stock solution and, immediately before use, ultra-filtered and added to the proliferation medium after sterilization. Toxicity tests were carried out on healthy tobacco and grapevine explants subjected to several drug concentrations (0.00, 0.10, 0.20, 0.30, 0.40 mM) for three repeated subcultures. The toxic threshold for an acceptable mortality rate was set at 30 % dead explants. The experimental design involved drug administration (solo or mixed) for six consecutive subcultures, for a total treatment time of 90 and 180 days for tobacco and grapevine, respectively. After each treatment, the apical portion (1-2 cm) of each explant was transferred to fresh supplemented medium and the residue was assayed by RT-PCR. Tests were repeated after 6 months to confirm virus elimination. Antiviral effectiveness was expressed as virus-free explants after six subcultures of treated explants. RT-qPCR was also performed to assess GLRaV-3 and CMV copies in explants. Specific primers based on the RNA-dependent RNA polymerase (RdRp) domains of GLRaV-3 and CMV were used (Feng et al. 2006; Velasco et al. 2014) . Relative quantitations of viruses were achieved by normalization of data to the concentration (Tsai et al. 2013; Velasco et al. 2014) . Infection level was expressed as virus copies in treated explants compared to control (%).
Electrophysiological measurements
For the in vivo amperometric measurements, carbon fiber microelectrodes (CFME) (tip diameter 5 lm) (Carbostar-1, Kation Scientific, USA) were used following Rinaldelli et al. (2012) . CFME were used in subsequent calibrations to test the linear response in the presence of the redox intermediary. Electrodes were placed in recording solution (RS) with a constant background of 5 9 10 -4 M potassium ferricyanide (K 3 [Fe(CN) 6 ]) (PF) adjusted to pH 5.6 by MES (2-(N-Morpholino)ethanesulfonic acid), and varying concentrations of potassium ferrocyanide (K 4 [Fe(CN) 6 ]) (0, 20, 50, 100 lM). The oxidation current, at an electrode potential of ?400 mV, was measured for each potassium ferrocyanide concentration. The current at the CFME surface rises because the impermeable intermediary ferrocyanide, generated by the reduction of ferricyanide by the cell reductase activity, is reoxidized by the CFME held at ?400 mV. Calibration curves were used to estimate the cell reductase activity expressed as [Fe 2? ] using oxidation current values before each treatment . Sample preparation and reductase activity detection were performed following Rinaldelli et al. (2012) . To stabilize the system before drug treatments, the leaf sample was maintained in RS until the oxidation current stabilized for at least 5 min. The RS was then extracted using a syringe and renewed, measuring oxidation current until stabilization. ] for each drug was calculated considering oxidation current after the last RS administration and oxidation current after drug administrations. Measurements were performed under Faraday cage.
NADH was quantified in healthy and infected samples in a colorimetric assay (450 nm) using NADH Quantification Kit (Sigma-Aldrich, St. Louis, MO, USA).
Statistical analysis
The effects of treatments on health status, D [Fe 2? ] and NADH were elaborated using Sigma-Plot software (version 11; Systat Software, San Jose, CA, USA). The software was used to perform analysis of variance (ANOVA) in a random design and pairwise multiple comparisons on significant effects and interactions using the Holm-Sidak method. All the experiments were performed in triplicate; each experiment consisted of 15 explants infected with each virus. Data expressed in percent were converted in arcsin values. P B 0.05 was considered to be significant.
Results and discussion
With regard to toxicity tests, no mortality in untreated healthy and infected explants was observed due to the micropropagation technique. A less than threshold-toxic effect on healthy explants treated with RB was detected at up to 0.10 mM, and up to 0.30 mM for TZ. No toxic effect was found for GS or AS treatments regardless of dosage up to 0.80 mM.
The antiviral effectiveness of TZ was significantly hindered by GS in both species (Fig. 1a, b) . GLRaV-3 infected explants were reduced by 37.0 % by TZ and by 7.0 % by RB, compared to the untreated infected control. GS at 0.40 mM reduced antiviral effects, setting activity of TZ and RB at 27.0 and 4.9 %, respectively, while AS up to 0.80 mM did not cause a reduction in GLRaV-3 infected explants. Analogous behavior was observed for CMV-infected explants, which were significantly reduced after administration of TZ and RB (66.0 and 7.3 %, respectively). Activity of TZ and RB was set at 27.0 and 5.1 %, respectively, after 0.40 mM GS administration, while AS caused no effects.
Infection levels followed a similar trend (Fig. 2a, b ). GLRaV-3 copies were reduced by 64.3 % by TZ and by 34.3 % by RB, compared to the untreated infected control. GS at 0.40 mM reduced antiviral effects, setting activity of TZ and RB at 48.2 and 25.0 % respectively, while AS up to 0.80 mM did not cause a reduction in GLRaV-3 copies. Analogous behavior was observed for CMV copies, which were significantly reduced after administration of TZ and RB (88.1 and 35.0 %, respectively). Activity of TZ and RB was set at 60.6 and 22.8 %, respectively, after 0.40 mM GS administration, while AS caused no effects. CMV and GLRaV-3 copies were unaltered by TZ adding 0.60 mM of GS, while a complete reversal of RB effectiveness was not achieved until 0.80 mM (Fig. 2a, b) .
Treatments with RB, TZ or GS caused a significant reduction of t-PMET activity in healthy or infected samples compared to untreated control. Differences were registered among drugs or GS administered at five doses, from 0.00 mM up to a threshold dose (0.20 mM for RB, 0.40 mM for TZ and 0.80 mM for GS). t-PMET activity of RB-treated samples was significantly reduced compared to the control in both species and regardless of health status (up to 37.5 or 48.4 % in healthy tobacco or grapevine; up to 31.2 or 34.6 % in infected tobacco or grapevine), while the effect of TZ was milder in the infected samples (up to 23.7 or 8.0 % in tobacco or grapevine). t-PMET activity was slightly reduced after GS administration (up to 11.1 or 14.0 % in healthy tobacco or grapevine; up to 21.4 or 14.6 % in infected tobacco or grapevine). In any case, t-PMET inhibition caused by RB, TZ or GS was dose dependent.
The inhibitory activity of t-PMET by drugs in healthy or infected grapevine samples was confirmed by NADH content. Infected grapevines showed higher NADH content (0.74 ± 0.04) compared to healthy ones (0.54 ± 0.05). A similar behavior was observed in tobacco (0.55 ± 0.04 in infected samples compared to 0.40 ± 0.04 in healthy ones). Both drugs applied at less than threshold-toxic concentrations (0.10 mM for RB, 0.30 mM for TZ) caused a significant NADH reduction in healthy samples (-18.5 % for RB, -16.7 % for TZ), while the higher content of NADH in infected plants interfered with drug activity, in particular against TZ . GS at 0.4 mM caused a 9.3 % decrement in NADH when applied alone, slightly enhancing the inhibitory activity of drugs. The same behavior was observed in tobacco samples.
In both species, the addition of GS to RB or TZ treatments did not seem to interfere with t-PMET until the GS administration at 0.50 mM (Fig. 2) . At higher dosages, GS reduced t-PMET activity during drug treatments. The GS concentration also represents a threshold with regard to inhibition of antiviral effectiveness expressed as infection level (Fig. 2) .
In conclusion, only GS was able to hinder the antiviral properties of both drugs, confirming that RB or TZ can interfere with GS pool. RB and TZ can also interfere with NAD ? /NADH conversion, altering t-PMET activity (Panattoni et al. 2013b ). Our tests demonstrate that inhibition of t-PMET by drugs depends on GS addition and its effect is dose dependent, confirming literature data (Glesne levels (expressed as virus copies in treated explants compared to control) of in vitro explants of (a) Nicotiana tabacum infected by CMV or (b) Vitis vinifera infected by GLRaV-3 et al. 1991) . Analogous trends were observed considering NADH tests. Our results suggest that exogenous GS up to 0.50 mM replenishes the GS pool depleted by drugs, contrasting antiviral action. At higher dosages, the TZ antiviral action was completely inhibited and exogenous GS caused a feedback that reduced t-PMET activity. The exogenous GS effect was partially against RB, suggesting that reduction of the GS pool contributed to the antiviral activity of RB, but it was not the only cause of antiviral effectiveness as was also found in Vero cells (Sepúlveda et al. 2012 ).
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